Reduced frequency of memory T cells and increased Th17 responses in patients with active tuberculosis

Clinical and Vaccine Immunology

Volumn 19, Issue 10, 2012, Pages 1667-1676

  Marín, Nancy D ^a   París, Sara C ^a   Rojas, Mauricio ^a   García, Luis F ^a  

^a UNIVERSIDAD DE ANTIOQUIA   (Colombia)

Author keywords

[No Author keywords available]

Indexed keywords

CD27 ANTIGEN; CD45RO ANTIGEN; CULTURE FILTRATE PROTEIN 10; GAMMA INTERFERON; INTERLEUKIN 17; TUBERCULIN;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EX VIVO STUDY; FEMALE; HUMAN; HUMAN CELL; LATENT TUBERCULOSIS; MALE; MEMORY T LYMPHOCYTE; PRIORITY JOURNAL; TH17 CELL; TUBERCULOSIS;

ADULT; ANTIGENS, BACTERIAL; ANTIGENS, CD27; ANTIGENS, CD45; BACTERIAL PROTEINS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; FEMALE; HUMANS; IMMUNOLOGIC MEMORY; INTERFERON-GAMMA; INTERLEUKIN-17; MALE; MYCOBACTERIUM TUBERCULOSIS; T-LYMPHOCYTE SUBSETS; TH17 CELLS; TUBERCULIN; TUBERCULOSIS;

EID: 84867257336     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00390-12     Document Type: Article

References (76)

1. Adetifa IM, et al. 2010. Decay kinetics of an interferon gamma release assay with anti-tuberculosis therapy in newly diagnosed tuberculosis cases. PLoS One 5:e12502. doi:10.1371/journal.pone.0012502.
2. Agger EM, Andersen P. 2001. Tuberculosis subunit vaccine development: on the role of interferon-gamma. Vaccine 19:2298-2302. (Pubitemid 32234231)
3. Andersen P, Doherty TM. 2005. The success and failure of BCG-implications for a novel tuberculosis vaccine. Nat. Rev. Microbiol. 3:656-662. (Pubitemid 41052152)
4. Annunziato F, et al. 2007. Phenotypic and functional features of human Th17 cells. J. Exp. Med. 204:1849-1861. (Pubitemid 47240944)
5. Appay V, van Lier RA, Sallusto F, Roederer M. 2008. Phenotype and function of human T lymphocyte subsets: consensus and issues. Cytometry A 73:975-983.
6. Beveridge NE, et al. 2008. A comparison of IFNgamma detection methods used in tuberculosis vaccine trials. Tuberculosis (Edinb.) 88:631-640.
7. Beverley PC. 1992. Functional analysis of human T cell subsets defined by CD45 isoform expression. Semin. Immunol. 4:35-41.
8. Caccamo N, et al. 2009. Analysis of Mycobacterium tuberculosis-specific CD8 T-cells in patients with active tuberculosis and in individuals with latent infection. PLoS One 4:e5528. doi:10.1371/journal.pone.0005528.
9. Casey R, et al. 2010. Enumeration of functional T-cell subsets by fluorescence-immunospot defines signatures of pathogen burden in tuberculosis. PLoS One 5:e15619. doi:10.1371/journal.pone.0015619.
10. Cehovin A, Cliff JM, Hill PC, Brookes RH, Dockrell HM. 2007. Extended culture enhances sensitivity of a gamma interferon assay for latent Mycobacterium tuberculosis infection. Clin. Vaccine Immunol. 14:796-798. (Pubitemid 47104772)
11. Chen X, et al. 2010. Reduced Th17 response in patients with tuberculosis correlates with IL-6R expression on CD4+ T cells. Am. J. Respir. Crit. Care Med. 181:734-742.
12. Cooper AM, Khader SA. 2008. The role of cytokines in the initiation, expansion, and control of cellular immunity to tuberculosis. Immunol. Rev. 226:191-204.
13. Cooper AM, Solache A, Khader SA. 2007. Interleukin-12 and tuberculosis: an old story revisited. Curr. Opin. Immunol. 19:441-447. (Pubitemid 47284862)
14. Cruz A, et al. 2006. Cutting edge: IFN-gamma regulates the induction and expansion of IL-17-producing CD4 T cells during mycobacterial infection. J. Immunol. 177:1416-1420. (Pubitemid 44092473)
15. De Jong R, et al. 1992. The CD27-subset of peripheral blood memory CD4+ lymphocytes contains functionally differentiated T lymphocytes that develop by persistent antigenic stimulation in vivo. Eur. J. Immunol. 22:993-999.
16. del Corral H, et al. 2009. IFNgamma response to Mycobacterium tuberculosis, risk of infection and disease in household contacts of tuberculosis patients in Colombia. PLoS One 4:e8257. doi:10.1371/journal.pone. 0008257.
17. Ellner JJ, Hirsch CS, Whalen CC. 2000. Correlates of protective immunity to Mycobacterium tuberculosis in humans. Clin. Infect. Dis. 30(Suppl 3):S279-S282. (Pubitemid 32250422)
18. Eum SY, et al. 2010. Neutrophils are the predominant infected phagocytic cells in the airways of patients with active pulmonary TB. Chest 137:122-128.
19. Fallen PR, et al. 2003. Identification of non-naive CD4+CD45RA+ T cell subsets in adult allogeneic haematopoietic cell transplant recipients. Bone Marrow Transplant. 32:609-616. (Pubitemid 37185097)
20. Flynn JL, et al. 1993. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 178:2249-2254. (Pubitemid 23344886)
21. Fritsch RD, et al. 2005. Stepwise differentiation of CD4 memory T cells defined by expression of CCR7 and CD27. J. Immunol. 175:6489-6497. (Pubitemid 41598891)
22. Geldmacher C, et al. 2010. Preferential infection and depletion of Mycobacterium tuberculosis-specific CD4 T cells after HIV-1 infection. J. Exp. Med. 207:2869-2881.
23. Goletti D, et al. 2006. Region of difference 1 antigen-specific CD4+ memory T cells correlate with a favorable outcome of tuberculosis. J. Infect. Dis. 194:984-992. (Pubitemid 44454084)
24. Hamann D, et al. 1997. Phenotypic and functional separation of memory and effector human CD8+ T cells. J. Exp. Med. 186:1407-1418. (Pubitemid 27479800)
25. Hanekom WA, et al. 2008. Immunological outcomes of new tuberculosis vaccine trials: WHO panel recommendations. PLoS Med. 5:e145. doi: 10.1371/journal.pmed.0050145.
26. Hanekom WA, et al. 2004. Novel application of a whole blood intracellular cytokine detection assay to quantitate specific T-cell frequency in field studies. J. Immunol. Methods 291:185-195. (Pubitemid 39164348)
27. Henao-Tamayo MI, et al. 2010. Phenotypic definition of effector and memory T-lymphocyte subsets in mice chronically infected with Mycobacterium tuberculosis. Clin. Vaccine Immunol. 17:618-625.
28. Hendriks J, et al. 2000. CD27 is required for generation and long-term maintenance of T cell immunity. Nat. Immunol. 1:433-440.
29. Higuchi K, Harada N, Fukazawa K, Mori T. 2008. Relationship between whole-blood interferon-gamma responses and the risk of active tuberculosis. Tuberculosis (Edinb.) 88:244-248.
30. Jacobs M, et al. 2007. Tumor necrosis factor is critical to control tuberculosis infection. Microbes Infect. 9:623-628. (Pubitemid 46628779)
31. Jacobsen M, et al. 2007. Clonal expansion of CD8+ effector T cells in childhood tuberculosis. J. Immunol. 179:1331-1339.
32. Jurado JO, et al. 2012. IL-17 and IFN-gamma expression in lymphocytes from patients with active tuberculosis correlates with the severity of the disease. J. Leukoc. Biol. 91:991-1002.
33. Kamath A, Woodworth JS, Behar SM. 2006. Antigen-specific CD8+ T cells and the development of central memory during Mycobacterium tuberculosis infection. J. Immunol. 177:6361-6369. (Pubitemid 44628855)
34. Keane J, et al. 2001. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N. Engl. J. Med. 345:1098-1104.
35. Khader SA, et al. 2007. IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat. Immunol. 8:369-377. (Pubitemid 46745412)
36. Khader SA, et al. 2005. IL-23 compensates for the absence of IL-12p70 and is essential for the IL-17 response during tuberculosis but is dispensable for protection and antigen-specific IFN-gamma responses if IL-12p70 is available. J. Immunol. 175:788-795. (Pubitemid 41094960)
37. Kolls JK, Linden A. 2004. Interleukin-17 family members and inflammation. Immunity 21:467-476. (Pubitemid 39370503)
38. Kwa D, Vingerhoed J, Boeser-Nunnink B, Broersen S, Schuitemaker H. 2001. Cytopathic effects of non-syncytium-inducing and syncytium-inducing human immunodeficiency virus type 1 variants on different CD4(+)-T-cell subsets are determined only by coreceptor expression. J. Virol. 75:10455-10459. (Pubitemid 32948075)
39. Lalvani A, Millington KA. 2008. T cells and tuberculosis: beyond inter-feron- gamma. J. Infect. Dis. 197:941-943. (Pubitemid 351590020)
40. Lanzavecchia A, Sallusto F. 2005. Understanding the generation and function of memory T cell subsets. Curr. Opin. Immunol. 17:326-332. (Pubitemid 40692670)
41. Leyten EM, et al. 2007. Discrepancy between Mycobacterium tuberculosis-specific gamma interferon release assays using short and prolonged in vitro incubation. Clin. Vaccine Immunol. 14:880-885.
42. Majlessi L, et al. 2006. An increase in antimycobacterial Th1-cell responses by prime-boost protocols of immunization does not enhance protection against tuberculosis. Infect. Immun. 74:2128-2137.
43. Marin ND, et al. 2010. Regulatory T cell frequency and modulation of IFN-gamma and IL-17 in active and latent tuberculosis. Tuberculosis (Edinb.) 90:252-261.
44. McKenzie BS, Kastelein RA, Cua DJ. 2006. Understanding the IL-23-IL-17 immune pathway. Trends Immunol. 27:17-23. (Pubitemid 43083560)
45. Millington KA, et al. 2007. Dynamic relationship between IFN-gamma and IL-2 profile of Mycobacterium tuberculosis-specific T cells and antigen load. J. Immunol. 178:5217-5226. (Pubitemid 46595306)
46. Mueller H, et al. 2008. Mycobacterium tuberculosis-specific CD4+, IFNgamma+, and TNFalpha+ multifunctional memory T cells coexpress GM-CSF. Cytokine 43:143-148.
47. Nandi B, Behar SM. 2011. Regulation of neutrophils by interferongamma limits lung inflammation during tuberculosis infection. J. Exp. Med. 208:2251-2262.
48. Newport MJ, et al. 1996. A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. N. Engl. J. Med. 335: 1941-1949. (Pubitemid 26428218)
49. Okamoto Yoshida Y, et al. 2010. Essential role of IL-17A in the formation of a mycobacterial infection-induced granuloma in the lung. J. Immunol. 184:4414-4422.
50. Pepper M, et al. 2010. Different routes of bacterial infection induce long-lived TH1 memory cells and short-lived TH17 cells. Nat. Immunol. 11:83-89.
51. Picker LJ, et al. 1995. Direct demonstration of cytokine synthesis heterogeneity among human memory/effector T cells by flow cytometry. Blood 86:1408-1419.
52. Qiao D, et al. 2011. ESAT-6-and CFP-10-specific Th1, Th22 and Th17 cells in tuberculous pleurisy may contribute to the local immune response against Mycobacterium tuberculosis infection. Scand. J. Immunol. 73: 330-337.
53. Qiu Z, et al. 2012. Multifunctional CD4 T cell responses in patients with active tuberculosis. Sci. Rep. 2:216. doi:10.1038/srep00216.
54. Rakotosamimanana N, et al. 2010. Variation in gamma interferon responses to different infecting strains of Mycobacterium tuberculosis in acid-fast bacillus smear-positive patients and household contacts in Antananarivo, Madagascar. Clin. Vaccine Immunol. 17:1094-1103.
55. Riano F, et al. 2012. T cell responses to DosR and Rpf proteins in actively and latently infected individuals from Colombia. Tuberculosis (Edinb.) 92:148-159.
56. Romero P, et al. 2007. Four functionally distinct populations of human effector-memory CD8+ T lymphocytes. J. Immunol. 178:4112-4119. (Pubitemid 46492360)
57. Rueda CM, Marin ND, Garcia LF, Rojas M. 2010. Characterization of CD4 and CD8 T cells producing IFN-gamma in human latent and active tuberculosis. Tuberculosis (Edinb.) 90:346-353.
58. Sahiratmadja E, et al. 2007. Dynamic changes in pro-and antiinflammatory cytokine profiles and gamma interferon receptor signaling integrity correlate with tuberculosis disease activity and response to curative treatment. Infect. Immun. 75:820-829. (Pubitemid 46203445)
59. Sallusto F, Geginat J, Lanzavecchia A. 2004. Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu. Rev. Immunol. 22:745-763. (Pubitemid 38680440)
60. Sargentini V, et al. 2009. Cytometric detection of antigen-specific IFNgamma/ IL-2 secreting cells in the diagnosis of tuberculosis. BMC Infect. Dis. 9:99. doi:10.1186/1471-2334-9-99.
61. Schiott A, Lindstedt M, Johansson-Lindbom B, Roggen E, Borrebaeck CA. 2004. CD27-CD4+ memory T cells define a differentiated memory population at both the functional and transcriptional levels. Immunology 113:363-370. (Pubitemid 39472153)
62. Scriba TJ, et al. 2008. Distinct, specific IL-17-and IL-22-producing CD4+ T cell subsets contribute to the human anti-mycobacterial immune response. J. Immunol. 180:1962-1970.
63. Serbina NV, Flynn JL. 2001. CD8(+) T cells participate in the memory immune response to Mycobacterium tuberculosis. Infect. Immun. 69: 4320-4328. (Pubitemid 32574428)
64. Shen T, et al. 2010. PD-1 expression on peripheral CD8+ TEM/TEMRA subsets closely correlated with HCV viral load in chronic hepatitis C patients. Virol. J. 7:310. doi:10.1186/1743-422X-7-310.
65. Shin H, Wherry EJ. 2007. CD8 T cell dysfunction during chronic viral infection. Curr. Opin. Immunol. 19:408-415. (Pubitemid 47284857)
66. Soares AP, et al. 2008. Bacillus Calmette-Guerin vaccination of human newborns induces T cells with complex cytokine and phenotypic profiles. J. Immunol. 180:3569-3577.
67. Stumhofer JS, Silver J, Hunter CA. 2007. Negative regulation of Th17 responses. Semin. Immunol. 19:394-399.
68. Sutherland JS, de Jong BC, Jeffries DJ, Adetifa IM, Ota MO. 2010. Production of TNF-alpha, IL-12(p40) and IL-17 can discriminate between active TB disease and latent infection in a West African cohort. PLoS One 5:e12365. doi:10.1371/journal.pone.0012365.
69. Tapaninen P, Korhonen A, Pusa L, Seppala I, Tuuminen T. 2010. Effector memory T-cells dominate immune responses in tuberculosis treatment: antigen or bacteria persistence? Int. J. Tuberc. Lung Dis. 14: 347-355.
70. Torrado E, Cooper AM. 2010. IL-17 and Th17 cells in tuberculosis. Cytokine Growth Factor Rev. 21:455-462.
71. Torrado E, Robinson RT, Cooper AM. 2011. Cellular response to mycobacteria: balancing protection and pathology. Trends Immunol. 32:66-72.
72. Tufariello JM, Chan J, Flynn JL. 2003. Latent tuberculosis: mechanisms of host and bacillus that contribute to persistent infection. Lancet Infect. Dis. 3:578-590. (Pubitemid 37064537)
73. Umemura M, et al. 2007. IL-17-mediated regulation of innate and acquired immune response against pulmonary Mycobacterium bovis bacille Calmette-Guerin infection. J. Immunol. 178:3786-3796. (Pubitemid 46417647)
74. Wang T, et al. 2011. Increased frequencies of T helper type 17 cells in tuberculous pleural effusion. Tuberculosis (Edinb.) 91:231-237.
75. Wang X, et al. 2010. Association of mycobacterial antigen-specific CD4(+) memory T cell subsets with outcome of pulmonary tuberculosis. J. Infect. 60:133-139.
76. World Health Organization. 2011. Global tuberculosis control: WHO report 2011. World Health Organization, Geneva, Switzerland.